六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioPharma(AYTU)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-23-005628 Act: 34 Size: 1 MB 网页链接
$Aytu BioPharma(AYTU)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-23-005631 Act: 34 Size: 573 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 1.01 and 2.03 Accession Number: 0001104659-23-037122 Act: 34 Size: 200 KB 网页链接
$Aytu BioPharma(AYTU)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-23-001645 Act: 34 Size: 11 MB 网页链接
$Aytu BioPharma(AYTU)$ 10-Q/A [Amend] Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-23-001643 Act: 34 Size: 12 MB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-23-001642 Act: 34 Size: 486 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, item 4.02 Accession Number: 0001104659-23-023779 Act: 34 Size: 202 KB 网页链接
$Aytu BioPharma(AYTU)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001104659-23-022422 Act: 34 Size: 32 KB 网页链接
$Aytu BioPharma(AYTU)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-021113 Act: 34 Size: 53 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001558370-23-001236 Act: 34 Size: 175 KB 网页链接